XellSmart
PrivateLast Round
Series C
Extension
Apr 2, 2026
Total Funding Raised
$185.64M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
XellSmart is a biotechnology company that develops clinical-grade, allogeneic, off-the-shelf, iPSC-derived cell therapies for central nervous system diseases such as Parkinson's and ALS.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XellSmart Comparables
Compare XellSmart with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai UniXell Biotechnology | 87% | |
| Kenai Therapeutics | 85% | |
| Nuwacell Biotechnologies Co., Ltd. | 82% |
XellSmart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Apr 2, 2026 | ||||
| Series B | Jan 14, 2026 | ||||
| Series A Extension | Apr 1, 2023 | ||||
| Series A Extension | Nov 8, 2022 | ||||
| Series A | Jan 9, 2022 | ||||
Pre Seed | Sep 8, 2021 |
XellSmart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Huatai Zijin Investment Co., Ltd. | Series A Extension |
| Fig | Series A Extension |
| Junshan Investment | Series A Extension |
| Oriza Holdings | Series A Extension |
| Tianjin TEDA Science and Technology Investment Co., Ltd. | Pre Seed, Angel |
| YuanBio Venture Capital | Pre Seed |
| Next Capital | Series A Extension, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 92% MoM.
- Jun 21, 2026
Monthly visitors increased 63% MoM.
XellSmart Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about XellSmart's valuation, stock price, and market status.
Is XellSmart a public or private company?
XellSmart is a private company.
What is the current stock price of XellSmart?
XellSmart is a private company with no public stock price. No recent secondary market data is available.
How much is XellSmart worth (valuation)?
Valuation information for XellSmart is not publicly available.
Can I buy XellSmart stock?
XellSmart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was XellSmart's last funding round?
XellSmart's most recent funding round was Series A Extension on April 18, 2023.
Who are the main investors in XellSmart?
Key investors in XellSmart include Fig, Gold Mountains Asset Management, Lilly Asia Ventures.
Will XellSmart IPO soon?
No public IPO plans have been announced for XellSmart.
How can I track XellSmart secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor XellSmart's secondary market activity and sign up for updates.